Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat

References

• UNAIDS. Data 2017. http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf.
   Google Scholar
• Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ. Trends in contraceptive use according to HIV status among privately insured women in the United States. Am J Obstet Gynecol. 2017;217(6):676 e1–676.e11.
   Web of Science ®Google Scholar
• Kaida A, Patterson S, Carter A, et al. Contraceptive choice and use of dual protection among women living with HIV in Canada: priorities for integrated care. Perspect Sex Reprod Health. 2017;49(4):223–236.
   PubMed Web of Science ®Google Scholar
• Kennedy VL, Serghides L, Raboud JM, et al. The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. AIDS Care. 2014;26(6):777–784.
   PubMed Web of Science ®Google Scholar
• Nostlinger C, Desjardins F, Dec J, Platteau T, Hasker E, Eurosupport V. Child desire in women and men living with HIV attending HIV outpatient clinics: evidence from a European multicentre study. Eur J Contracept Reprod Health Care. 2013;18(4):251–263.
   PubMed Web of Science ®Google Scholar
• Aizire J, Yende N, Nematadzira T, et al., eds. High frequency of unintended pregnancy and predictors of contraceptive choice among HIV-infected African women on life-long antiretroviral therapy (ART). The US-PEPFAR PROMOTE Cohort Study. Presented at: 22nd International AIDS Conference (AIDS 2018) abstract THAB0301; July 2018; Amsterdam.
   Google Scholar
• Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Report. No 86. Hyattsville, MD: National Center for Health Statistics.
   Google Scholar
• Statistics on sexual and reproductive health services; England 2015/16. Lifestyles Team, NHS Digital. Published 19 October 2016. Available at: https://files.digital.nhs.uk/publicationimport/pub21xxx/pub21969/srh-serv-eng-15-16-rep.pdf. Accessed 3rd July 2019.
   Google Scholar
• Thurman AR, Anderson S, Doncel GF. Effects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamics. Am J Reprod Immunol. 2014;71(6):523–530.
   PubMed Web of Science ®Google Scholar
• McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception. 1994;50(6 Suppl 1):S1–S195.
   PubMed Web of Science ®Google Scholar
• Phillips S, Steyn P, Temmerman M. Contraceptive options for women living with HIV. Best Pract Res Clin Obstet Gynaecol. 2014;28(6):881–890.
   Web of Science ®Google Scholar
• Pyra M, Heffron R, Mugo NR, et al. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS. 2015;29(17):2353–2359.
   PubMed Web of Science ®Google Scholar
• Microgynon 30ED. Summary of Product Characteristics. Bayer plc, 400 South Oak Way, Reading RG2 6AD. (Updated August 2017; Accessed August 2018). Available at: https://www.medicines.org.uk/emc/product/1131/smpc.
   Google Scholar
• Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–181.
   PubMed Web of Science ®Google Scholar
• Patterson S, Carter A, Nicholson V, et al. Condomless sex among virally suppressed women with HIV with regular HIV-serodiscordant sexual partners in the era of treatment as prevention. J Acquir Immune Defic Syndr. 2017;76(4):372–381.
   Web of Science ®Google Scholar
• Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016;19(3 Suppl 2):20810.
   PubMedGoogle Scholar
• Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–222.
   PubMed Web of Science ®Google Scholar
• Kellogg TA, Clements-Nolle K, Dilley J, Katz MH, McFarland W. Incidence of human immunodeficiency virus among male-to-female transgendered persons in San Francisco. J Acquir Immune Defic Syndr. 2001;28(4):380–384.
   PubMed Web of Science ®Google Scholar
• Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016;28(8):976–981.
   PubMed Web of Science ®Google Scholar
• Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–433.
   PubMed Web of Science ®Google Scholar
• Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization [PAHO], J.S., Inc., World Professional Association for Transgender and e.a. Health, Blueprint for the Provision of Comprehensive Care for Trans Persons and Their Communities in the Caribbean and Other Anglophone Countries. Arlington, VA: John Snow Inc; 2014.
   Google Scholar
• Winter S, Doussantousse S. Transpeople, hormones, and health risks in Southeast Asia: a lao study. Int J Sex Health. 2009;21(1):35.
   Web of Science ®Google Scholar
• Battegay M, Lundgren JD, Ryom L. European AIDS Clinical Society. Clinical management and treatment of HIV-infected patients in Europe. V 9.0. October 2017. Available from: http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html. Accessed 4 July 2018.
   Google Scholar
• U.S. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0. Aids Info Updated May 2018. Accessed August 2018.
   Google Scholar
• Waters L. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update). http://www.bhiva.org/documents/Guidelines/Treatment/2016/treatment-guidelines-2016-interim-update.pdf. BHIVA. Accessed December 19, 2017.
   Google Scholar
• World Health Organisation: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. Second edition 2016. Available at: http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=06AB15554EB92AB1DD391D39FFBF642F?sequence=1. Accessed September 17, 2018.
   Google Scholar
• Elliot ER, Amara A, Pagani N, et al. Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge. J Antimicrob Chemother. 2017;72(7):2143.
   Web of Science ®Google Scholar
• Tittle V, Bull L, Boffito M, Nwokolo N. Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives. Clin Pharmacokinet. 2015;54(1):23–34.
   PubMed Web of Science ®Google Scholar
• Atrio J, Stanczyk FZ, Neely M, Cherala G, Kovacs A, Mishell DR Jr. Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. J Acquir Immune Defic Syndr. 2014;65(1):72–77.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chung E, Yones C, et al. The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women. Antivir Ther. 2011;16(2):157–164.
   PubMed Web of Science ®Google Scholar
• Tackett D CM, Agarwala S, et al., eds. Atazanavir: a summary of two pharmacokinetic drug interaction studies in healthy subjects. Presented at: 10th Conference on Retrovirus and Opportunistic Infections; February 10–14, 2003; Boston.
   Google Scholar
• FSRH Clinical Effectiveness Unit. Hormonal contraception. Available from https://www.fsrh.org/standards-and-guidance/documents/combined-hormonal-contraception/. Update August 2012. Accessed August 2018)
   Google Scholar
• Marzolini C, Gibbons S, Khoo S, Back D. Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. J Antimicrob Chemother. 2016;71(7):1755–1758.
   PubMed Web of Science ®Google Scholar
• Evotaz: Atazanavir/cobicistat 300 mg/150 mg film-coated tablets summary of product characteristics. Bristol-Myers Squibb Pharmaceutical Limited, Uxbridge, UK. Availbale at: https://www.medicines.org.uk/emc/product/7006. Update February 2018. Accessed August 2018.
   Google Scholar
• University of Liverpool HIV Drug Interaction Checker. Available at: https://www.hiv-druginteractions.org Accessed May 11, 2019
   Google Scholar
• Majeed SR, West SK, Shuping J, et al., eds. Confirmation of the drug–drug interaction potential between cobicistat-boosted antiretroviral regimen. Paper presented at: IWCPAT; 2017; Chicago.
   Google Scholar
• Blode H, Wuttke W, Loock W, Roll G, Heithecker R. A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur J Contracept Reprod Health Care. 2000;5(4):256–264.
   PubMedGoogle Scholar
• Statista Report. Number of items of leading contraceptive pills prescribed in England in 2015. Available at: https://www.statista.com/statistics/573336/leading-contraceptive-pills-prescribed-in-england/. Accessed May 11, 2019.
   Google Scholar
• https://www.liverpool.ac.uk/translational-medicine/research/bioanalytical-facility/about/
   Google Scholar
• http://kkgt.nl/?page_id=248&lang=en.
   Google Scholar
• Cirrincione LR, Penchala SD, Scarsi KK, et al. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1084:106–112.
   Web of Science ®Google Scholar
• Else L, Watson V, Tjia J, et al. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(19):1455–1465.
   Web of Science ®Google Scholar
• Penchala SD, Fawcett S, Else L, et al. The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1027:174–180.
   PubMed Web of Science ®Google Scholar
• Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am. 1992;21(3):511–526.
   PubMed Web of Science ®Google Scholar
• Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev. 1995;27(3):397–417.
   PubMed Web of Science ®Google Scholar
• Levonelle 1500 microgram tablet Summary of Product Characteristics. Bayer plc, 400 South Oak Way, Reading RG2 6AD. Available at: https://www.medicines.org.uk/emc/product/133. Updated March 2018. Accessed August 2018.
   Google Scholar
• Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181(5):1263–1269.
   PubMed Web of Science ®Google Scholar
• Sondheimer SJ. Oral contraceptives: mechanism of action, dosing, safety, and efficacy. Cutis 2008;81(1 Suppl):19–22.
   Web of Science ®Google Scholar
• Olsson B, Landgren BM. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel. Clin Ther. 2001;23(11):1876–1888.
   Web of Science ®Google Scholar
• Teofilo E, Rocha-Pereira N, Kuhlmann B, et al. Long-term efficacy, tolerability, and renal safety of atazanavir/ritonavir-based antiretroviral therapy in a cohort of treatment-naive patients with HIV-1 infection: the REMAIN study. HIV Clin Trials. 2016;17(1):17–28.
   PubMed Web of Science ®Google Scholar